Stream: biopharma
Topic: New Project: Investigating use of FHIR in Clinical Research
Geoff Low (Feb 15 2017 at 23:28):
Hey there. The PhUSE Steering committee has approved the New FHIR project to look at use cases for adoption and utilisation of FHIR as part of the Clinical Trials process. I appreciate there may be some overlap with existing projects/initiatives within the FHIR community, however we want to work together so we are open to anyone who wishes to participate. There are two scheduled F2F (one in Washington, DC and another in London, UK). We have been promised at least one representative from the FDA. If you are interested in this, please ping me.
Pascal Pfiffner (Feb 16 2017 at 16:13):
Geoff, what are the prospective dates for these meetings?
Geoff Low (Feb 21 2017 at 13:43):
The immediate term meeting will be the 19th - 21st March Silver Spring event (http://www.phuse.eu/css) and the european event will be the 19th & 20th June 2017 in London (http://www.phuse.eu/eu-css-2017). We will also be running weekly/bi-weekly calls, let me know if you are interested in attending.
Geoff Low (Feb 21 2017 at 13:46):
@Wai Keong Wong FYI!
Geoff Low (Apr 03 2017 at 07:18):
Thank you so much for either attending the FHIR working group meeting at CSS or expressing interest in participating in the Exploring the Use of FHIR in Clinical Research (a.k.a., Research on FHIR) team.
Please complete this When Is Good survey (http://whenisgood.net/jd7kc7f) so that we can set up our weekly meetings. Ignore the dates associated with each option in the survey, we will meet each Tuesday, Wednesday, or Thursday at one of the provided time options (8:00-9:00; 9:00-10:00; 10:00-11:00, or 11:00-12:00 Eastern).
(from the co-lead of the PhUSE FHIR in Clinical Research team). Attn: @Lloyd McKenzie @Wai Keong Wong
Last updated: Apr 12 2022 at 19:14 UTC
